585540-04-1 Usage
Uses
Used in Pharmaceutical Industry:
Cyclohexaneacetic acid, 1-(aminomethyl)-, sulfate (1:1) is used as an intermediate in the synthesis of various drugs for its ability to act as a building block in the production of diverse pharmaceuticals, including antidepressants and antihistamines.
Used in Research and Development:
Cyclohexaneacetic acid, 1-(aminomethyl)-, sulfate (1:1) is utilized in the research and development of new medicinal compounds, contributing to the discovery and creation of innovative pharmaceuticals.
Safety Precautions:
It is important to handle Cyclohexaneacetic acid, 1-(aminomethyl)-, sulfate (1:1) with care and according to safety protocols due to potential health hazards associated with its use. Proper handling and storage are essential to minimize risks and ensure the safety of those working with this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 585540-04-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,5,5,4 and 0 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 585540-04:
(8*5)+(7*8)+(6*5)+(5*5)+(4*4)+(3*0)+(2*0)+(1*4)=171
171 % 10 = 1
So 585540-04-1 is a valid CAS Registry Number.
585540-04-1Relevant articles and documents
IMPROVED PROCESS FOR PREPARATION OF GABAPENTIN
-
Page 5, (2008/06/13)
A process for producing Gabapentin, (1-(aminomethyl)-1-cyclohexaneacetic acid) from Gabapentin hydrochloride salt. In the process the Gabapentin hydrochloride is converted to Gabapentin using inorganic base such as Barium hydroxide. Gabapentin hydrochloride is converted to Gabapentin sulfate which in turn is converted to free base using Barium hydroxide. The process is directed to improvement in the manufacture of Gabapentin which would be industrially feasible and effective Gabapentin obtained following the process of the invention is suitable as a drug especially in the treatment of cerebral diseases such as epilepsy. The above process involves simple steps and avoid the problems of the known art. In particular the process avoids severe conditions and/or complexities and can be readily adopted for industrial application. The process provides for good yield and does not involve lenghty extended process steps. It is cost-effective and can be carried out involving simple ingredients and steps of manufacture.
